Scientologist Director Slams Psychiatry, Quits
I always find it amusing to read stories like this. Scientology dismisses, out of hand, the work of hundreds of thousands of researchers, scientists, psychologists, and psychiatrists in trying to understand the human brain and human behavior and has the nerve to suggest it is a “pseudo-science.” I can’t imagine what those two-bit peer-reviewed journals such as JAMA and the NEJM have been doing all of these decades publishing such “junk” science!
When Joseph Feshbach, a Scientologist, joined QuadraMed Corp.’s board in 2001 he didn’t think the health-care information technology company would ever involve itself with the “pseudo-science” of psychiatry.
So when the company decided to market its pharmacy software to psychiatric hospitals, Feshbach quit.
“Psychiatry is a pseudo-science and its practices, including the widespread use of psychotropics, is leaving widespread misery and even death in its wake,” Feshbach told the board in his resignation letter filed Tuesday with the Securities and Exchange Commission.
A spokeswoman for the Reston, Va., company declined to discuss Feshbach’s decision.
Comments
This post currently has no comments. You can read the comments or leave your own thoughts on our new comments page.
Trackbacks
Last reviewed: By John M. Grohol, Psy.D. on 12 Jan 2006
Published on PsychCentral.com. All rights reserved.
Grohol, J. (2006). Scientologist Director Slams Psychiatry, Quits. Psych Central. Retrieved on May 25, 2012, from http://psychcentral.com/blog/archives/2006/01/12/scientologist-director-slams-psychiatry-quits/


Dr. John Grohol is the CEO and founder of Psych Central. He is an author, researcher and expert in mental health online, and has been writing about online behavior, mental health and psychology issues -- as well as the intersection of technology and human behavior -- since 1992. Dr. Grohol sits on the editorial board of the journal Cyberpsychology, Behavior and Social Networking and is a founding board member and treasurer of the Society for Participatory Medicine.